The investigation revealed 14 variants in ten genes (PMS2, PDGFRB, PREX2, ATM, MET, PRKN, DDX41, KDM5C, KMT2C and HLA-A) in patient samples that were pathogenic/likely pathogenic in AML/MDS. The gene discussed is MET; the disease is myelodysplastic syndrome.